001     306343
005     20251122115852.0
024 7 _ |a 10.1093/neuonc/noaf237
|2 doi
024 7 _ |a pmid:41259653
|2 pmid
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
037 _ _ |a DKFZ-2025-02559
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Landry, Alexander P
|b 0
245 _ _ |a A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma.
260 _ _ |a Oxford
|c 2025
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763732918_2665072
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patients. To allow for seamless integration of these complementary models into clinical practice, a practical framework is needed.We leveraged a cohort of nearly 2000 surgically-treated meningiomas with DNA methylation profiling and clinical outcomes data. Existing methylation-based prediction models were dichotomized to yield four risk groups: low and high recurrent risk, each with RT sensitive and resistant subgroups. Risk groups were correlated with progression-free survival in the context of existing biomarkers including extent of resection and WHO grade.We first demonstrated that all risk groups benefit from gross total resection. All 'high-risk, RT sensitive' tumors (n = 306, 15.7%) also benefited from adjuvant RT: after GTR, median PFS increased from 4.68 (4.13-9.48) years to not reached (p = 0.003); after STR, from 2.12 (1.59-3.02) to 4.09 (3.41-not reached) years (p = 0.004). 'Low-risk, RT sensitive cases' (n = 1207, 61.8%) also benefitted from RT after STR (median PFS 7.39 (6.66-12.8) vs. 16.53 (10.35-not reached) years, p = 0.03), suggesting that RT be considered in these patients. Neither 'low-risk RT resistant' (n = 84, 4.3%) nor 'high-risk RT resistant' (n = 356, 18.2%) cases benefitted from RT, and the latter group was associated with universally poor outcomes.We identify methylation-defined risk groups of meningioma for which additional benefit is gained from adjuvant RT, leading to a clinical decision-making framework for straightforward integration of molecular models into clinical practice.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a DNA methylation
|2 Other
650 _ 7 |a Meningioma
|2 Other
650 _ 7 |a clinical recommendations
|2 Other
650 _ 7 |a neuro-oncology
|2 Other
650 _ 7 |a outcome biomarker
|2 Other
700 1 _ |a Wang, Justin Z
|b 1
700 1 _ |a Patil, Vikas
|b 2
700 1 _ |a Ajisebutu, Andrew
|b 3
700 1 _ |a Gui, Chloe
|b 4
700 1 _ |a Yefet, Leeor S
|b 5
700 1 _ |a Ellenbogen, Yosef
|b 6
700 1 _ |a Liu, Jeff
|b 7
700 1 _ |a Mamatjan, Yasin
|b 8
700 1 _ |a Wei, Qingxia
|b 9
700 1 _ |a Singh, Olivia
|b 10
700 1 _ |a Mansouri, Sheila
|b 11
700 1 _ |a Ehret, Felix
|b 12
700 1 _ |a Capper, David
|0 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
|b 13
|u dkfz
700 1 _ |a Cohen-Gadol, Aaron A
|b 14
700 1 _ |a Tabatabai, Ghazaleh
|0 P:(DE-He78)d53ff17be4b468909d803eccd92df3d6
|b 15
|u dkfz
700 1 _ |a Tatagiba, Marcos
|b 16
700 1 _ |a Behling, Felix
|b 17
700 1 _ |a Barnholtz-Sloan, Jill S
|b 18
700 1 _ |a Sloan, Andrew E
|b 19
700 1 _ |a Chambless, Lola B
|b 20
700 1 _ |a Mansouri, Alireza
|b 21
700 1 _ |a Makarenko, Serge
|b 22
700 1 _ |a Yip, Stephen
|b 23
700 1 _ |a Tsang, Derek S
|b 24
700 1 _ |a Gao, Andrew
|b 25
700 1 _ |a Meningiomas, International Consortium On
|b 26
|e Collaboration Author
700 1 _ |a Aldape, Kenneth
|b 27
700 1 _ |a Nassiri, Farshad
|b 28
700 1 _ |a Zadeh, Gelareh
|b 29
700 1 _ |a Santarius, Thomas
|b 30
|e Contributor
700 1 _ |a Selman, Warren
|b 31
|e Contributor
700 1 _ |a Couce, Marta
|b 32
|e Contributor
700 1 _ |a Sloan, Andrew E
|b 33
|e Contributor
700 1 _ |a Brastianos, Priscilla K
|b 34
|e Contributor
700 1 _ |a Shih, Helen A
|b 35
|e Contributor
700 1 _ |a Bi, W Linda
|b 36
|e Contributor
700 1 _ |a Huang, Raymond Y
|b 37
|e Contributor
700 1 _ |a Wen, Patrick Y
|b 38
|e Contributor
700 1 _ |a Walbert, Tobias
|b 39
|e Contributor
700 1 _ |a Lee, Ian
|b 40
|e Contributor
700 1 _ |a Felicella, Michelle
|b 41
|e Contributor
700 1 _ |a Brodie, Chaya
|b 42
|e Contributor
700 1 _ |a Malta, Tathiane
|b 43
|e Contributor
700 1 _ |a Castro, Ana Valeria C
|b 44
|e Contributor
700 1 _ |a Noushmehr, Houtan
|b 45
|e Contributor
700 1 _ |a Snyder, James
|b 46
|e Contributor
700 1 _ |a Dimeco, Francesco
|b 47
|e Contributor
700 1 _ |a Saladino, Andrea
|b 48
|e Contributor
700 1 _ |a Pollo, Bianca
|b 49
|e Contributor
700 1 _ |a Schichor, Christian
|b 50
|e Contributor
700 1 _ |a Tonn, Jorg-Christian
|b 51
|e Contributor
700 1 _ |a Kaufmann, Timothy J
|b 52
|e Contributor
700 1 _ |a Lachance, Daniel
|b 53
|e Contributor
700 1 _ |a Giannini, Caterina
|b 54
|e Contributor
700 1 _ |a Galanis, Evanthia
|b 55
|e Contributor
700 1 _ |a Raghunathan, Aditya
|b 56
|e Contributor
700 1 _ |a Hanemann, C Oliver
|b 57
|e Contributor
700 1 _ |a Au, Karolyn
|b 58
|e Contributor
700 1 _ |a Goldbrunner, Roland
|b 59
|e Contributor
700 1 _ |a Galldiks, Norbert
|b 60
|e Contributor
700 1 _ |a Timmer, Marco
|b 61
|e Contributor
700 1 _ |a Schimdt, Nils Ole
|b 62
|e Contributor
700 1 _ |a Herold-Mende, Christel
|b 63
|e Contributor
700 1 _ |a Sahm, Felix
|0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
|b 64
|e Contributor
|u dkfz
700 1 _ |a Jungk, Christine
|b 65
|e Contributor
700 1 _ |a Jungwirth, Gerhard
|b 66
|e Contributor
700 1 _ |a Von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 67
|e Contributor
|u dkfz
700 1 _ |a Jenkinson, Michael D
|b 68
|e Contributor
700 1 _ |a Millward, Christopher P
|b 69
|e Contributor
700 1 _ |a Islim, Abdurrahman I
|b 70
|e Contributor
700 1 _ |a Drummond, Katharine
|b 71
|e Contributor
700 1 _ |a Morokoff, Andrew
|b 72
|e Contributor
700 1 _ |a Tabatabai, Ghazaleh
|0 P:(DE-He78)d53ff17be4b468909d803eccd92df3d6
|b 73
|e Contributor
|u dkfz
700 1 _ |a Behling, Felix
|b 74
|e Contributor
700 1 _ |a Renovanz, Mirjam
|b 75
|e Contributor
700 1 _ |a Tatagiba, Marcos
|b 76
|e Contributor
700 1 _ |a Santacroce, Antonio
|b 77
|e Contributor
700 1 _ |a Fougere, Christian la
|b 78
|e Contributor
700 1 _ |a Schittenhelm, Jens
|b 79
|e Contributor
700 1 _ |a Raleigh, David R
|b 80
|e Contributor
700 1 _ |a Perry, Arie
|b 81
|e Contributor
700 1 _ |a Butowski, Nicholas
|b 82
|e Contributor
700 1 _ |a Westphal, Manfred
|b 83
|e Contributor
700 1 _ |a Lamszus, Katrin
|b 84
|e Contributor
700 1 _ |a Ricklefs, Franz
|b 85
|e Contributor
700 1 _ |a Mawrin, Christian
|b 86
|e Contributor
700 1 _ |a Horbinski, Craig M
|b 87
|e Contributor
700 1 _ |a Ng, Ho-Keung
|b 88
|e Contributor
700 1 _ |a Snuderl, Matija
|b 89
|e Contributor
700 1 _ |a Kurz, Sylvia
|b 90
|e Contributor
700 1 _ |a Sulman, Erik P
|b 91
|e Contributor
700 1 _ |a Zada, Gabriel
|b 92
|e Contributor
700 1 _ |a Cohen-Gadol, Aaron
|b 93
|e Contributor
700 1 _ |a Yip, Stephen
|b 94
|e Contributor
700 1 _ |a Makarenko, Serge
|b 95
|e Contributor
700 1 _ |a Zherebitskiy, Viktor
|b 96
|e Contributor
700 1 _ |a Hnenny, Luke
|b 97
|e Contributor
700 1 _ |a Dunn, Ian F
|b 98
|e Contributor
700 1 _ |a Moliterno, Jennifer
|b 99
|e Contributor
700 1 _ |a McDermott, Michael W
|b 100
|e Contributor
700 1 _ |a Vogelbaum, Michael
|b 101
|e Contributor
700 1 _ |a Javadpour, Mohsen
|b 102
|e Contributor
700 1 _ |a Fountain, Daniel
|b 103
|e Contributor
700 1 _ |a Mathiesen, Tiit Illimar
|b 104
|e Contributor
700 1 _ |a Aldape, Kenneth
|b 105
|e Contributor
700 1 _ |a Barnholtz-Sloan, Jill
|b 106
|e Contributor
700 1 _ |a Pathmanaban, Omar
|b 107
|e Contributor
700 1 _ |a Boutros, Paul C
|b 108
|e Contributor
700 1 _ |a Alkividias, Tzannis
|b 109
|e Contributor
700 1 _ |a Fountas, Konstantinos N
|b 110
|e Contributor
700 1 _ |a Walsh, Kyle M
|b 111
|e Contributor
700 1 _ |a Short, Susan C
|b 112
|e Contributor
700 1 _ |a Carvalho, Bruno
|b 113
|e Contributor
700 1 _ |a Maas, Sybren L N
|b 114
|e Contributor
700 1 _ |a Bos, Eelke M
|b 115
|e Contributor
700 1 _ |a Dincer, Alper
|b 116
|e Contributor
700 1 _ |a Kurz, Sylvia
|b 117
|e Contributor
700 1 _ |a Passlack, Peter
|b 118
|e Contributor
700 1 _ |a Deng, Maximilian
|b 119
|e Contributor
700 1 _ |a Ehrat, Felix
|b 120
|e Contributor
700 1 _ |a Mehta, Minesh P
|b 121
|e Contributor
700 1 _ |a Odia, Yazmin
|b 122
|e Contributor
700 1 _ |a Everson, Richard
|b 123
|e Contributor
700 1 _ |a Balogun, James A
|b 124
|e Contributor
700 1 _ |a Lopez, Clara
|b 125
|e Contributor
700 1 _ |a Calabrese, Evan
|b 126
|e Contributor
700 1 _ |a Karschnia, Philipp
|b 127
|e Contributor
700 1 _ |a Teske, Nico
|b 128
|e Contributor
700 1 _ |a Fariselli, Laura
|b 129
|e Contributor
700 1 _ |a Greve, Tobias
|b 130
|e Contributor
700 1 _ |a Arvaniti, Christina
|b 131
|e Contributor
700 1 _ |a Benjamin, Carolina
|b 132
|e Contributor
700 1 _ |a Ivan, Michael
|b 133
|e Contributor
700 1 _ |a Jackson, Christina
|b 134
|e Contributor
700 1 _ |a Jeyaretna, Sanjeeva
|b 135
|e Contributor
700 1 _ |a Scartoni, Daniele
|b 136
|e Contributor
700 1 _ |a Amelio, Dante
|b 137
|e Contributor
700 1 _ |a Palmer, Joshua
|b 138
|e Contributor
700 1 _ |a Ivanidze, Jana
|b 139
|e Contributor
700 1 _ |a Ostrom, Quinn
|b 140
|e Contributor
700 1 _ |a Kien, Duong Trung
|b 141
|e Contributor
700 1 _ |a Youngblood, Mark
|b 142
|e Contributor
700 1 _ |a Millareschavez, Miguel
|b 143
|e Contributor
700 1 _ |a AlThgafi, Malak
|b 144
|e Contributor
700 1 _ |a Emerson, Sam
|b 145
|e Contributor
700 1 _ |a Weller, Michael
|b 146
|e Contributor
700 1 _ |a LeRhun, Emilie
|b 147
|e Contributor
700 1 _ |a Martínez-Pérez, Rafael
|b 148
|e Contributor
700 1 _ |a Smee, Robert
|b 149
|e Contributor
700 1 _ |a Mukherjee, Raj
|b 150
|e Contributor
700 1 _ |a Cervio, Andres
|b 151
|e Contributor
700 1 _ |a Turner, Clinton
|b 152
|e Contributor
700 1 _ |a Muirhead, Will
|b 153
|e Contributor
700 1 _ |a Suero, Eric
|b 154
|e Contributor
700 1 _ |a Julius, Vitowanu
|b 155
|e Contributor
700 1 _ |a Chen, Jiawei
|b 156
|e Contributor
700 1 _ |a Karmur, Brij
|b 157
|e Contributor
700 1 _ |a Mrugala, Maciej
|b 158
|e Contributor
700 1 _ |a Neth, Brian
|b 159
|e Contributor
773 _ _ |a 10.1093/neuonc/noaf237
|g p. noaf237
|0 PERI:(DE-600)2094060-9
|p nn
|t Neuro-Oncology
|v nn
|y 2025
|x 1522-8517
909 C O |o oai:inrepo02.dkfz.de:306343
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)d53ff17be4b468909d803eccd92df3d6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 64
|6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 67
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 73
|6 P:(DE-He78)d53ff17be4b468909d803eccd92df3d6
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-11
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-11
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2024-12-11
920 1 _ |0 I:(DE-He78)BE01-20160331
|k BE01
|l DKTK Koordinierungsstelle Berlin
|x 0
920 1 _ |0 I:(DE-He78)TU01-20160331
|k TU01
|l DKTK Koordinierungsstelle Tübingen
|x 1
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)BE01-20160331
980 _ _ |a I:(DE-He78)TU01-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21